Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Linking an insect enzyme to hypertension: angiotensin II–epoxide hydrolase interactions
Kidney International, 10/27/09
Ai D et al. – Because of the close association of the angiotensin II/soluble epoxide hydrolase/epoxyeicosatrienoic acid system and blood pressure regulation, pharmacological inhibition of soluble epoxide hydrolase would be a useful approach to prevent and treat angiotensin II–induced cardiac hypertrophy and hypertension, as well as vascular impairments.
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
The Lancet, 03/15/10
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension
The Lancet, 03/15/10
Is Pulse Pressure a Predictor of New-onset Diabetes in High-risk Hypertensive Patients?: A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
Diabetes Care, 03/15/10
Article Search
Sponsor
Sponsor


See Latest Articles


